Accu-Break Pharmaceuticals (ABP), the US company with a suite of
tableting technologies for creating divisible dosage forms, has
signed a co-operation agreement with Germany's Midas Pharma that
should open new avenues for technology...
A new recombinant pig liver esterase (PLE) biocatalyst that
sidesteps concerns about the safety of animal-derived versions has
been launched by DSM Pharma Chemicals.
Aceto, the US-based distributor and marketer of fine and industrial
chemicals, is making a determined pitch for the pharmaceutical
intermediates sector in Japan.
Questions are hanging over the role of a Chinese manufacturing
facility in the Baxter heparin scare after it has emerged that the
US Food and Drug Administration (FDA) has never inspected the
facility.
Germany put in a strong showing as category winners were announced
for the fourth annual Facility of the Year Awards (FOYA)
recognising innovation in pharmaceutical manufacturing projects.
Alpharma has signed a definitive agreement with private equity
group 3i for the sale of its active pharmaceutical ingredient (API)
business, pocketing $395m in the deal to reinvest in its
pharmaceutical and animal health divisions.
Researchers can now reduce the cost and time taken to breed goats
that can produce therapeutic proteins using gene therapy.
Experts say these transgenic animals could cut the cost of insulin
and other cancer-fighting proteins.
A delegation from the Scotland's chemicals industry descended on
the recent Informex trade show in New Orleans, determined to
convince the assembled industry representatives that the country
should be at the top of the list for...
In any laboratory, or indeed in any pharmaceutical manufacturing
facility, one of the major expenses will be solvents. And just like
the price of petrol and diesel it just keeps going up and up.
Huw Kidwell examines how a new recycling...
In the world of chemistry the majority of reactions are well known
and have been around for a very long time producing similar
compounds. It is not very often that a completely new reaction
methodology comes along which can turn something...
Another sharp decline in biomedical production saw overall
manufacturing output in Singapore fall for the second month running
in December, prompting fears that the heavily trade-reliant economy
could buckle under a looming US recession.
Nabi Biopharmaceuticals this week announced that is considering a
possible sale or merger of the company, with 'multiple entities'
apparently interested in the business.
With the price of crude oil going up almost every day it is no
surprise that this has a knock-on effect to the price of raw
materials for the pharmaceutical and chemical industries. But DSM
and Roquette have developed a process that...
Novartis has announced the US approval of its first-in-class blood
pressure med Tekturna (aliskiren) combined with a diuretic in a
single-tablet formulation.
Canadian vaccine specialist ImmunoVaccine Technologies (IVT) has
scored a multi-million dollar grant to go towards developing its
potent immune enhancement systems.
Chemical and intermediates firm Lanxess has announced that its
subsidiary Saltigo is the proud new owner of a site in Washington
in the US, formerly used by Eli Lilly subsidiary, ICOS.
Novartis has been keen to shout about data published this week in
the Journal of the American Medical Association (JAMA)
that backs up claims that it has developed the first vaccine to
protect infants against the most common meningitis...
A starch-based film coating for nutraceuticals which can be
tailored to manufacturer's needs is being developed through a
strategic partnership by Roquette and Biogrund.
Dutch firm Crucell last week announced that it has entered into an
agreement with vaccine specialist Sanofi Pasteur for its next
generation rabies antibody cocktail.
Merck & Co has handed the reins of one of its US active
pharmaceutical ingredient (API) manufacturing facilities over to
new a owner, who has also secured a lucrative contract
manufacturing deal with the drug giant.
A team of US researchers have uncovered a cocktail of three drugs
that could be effective at treating every patient with a particular
type of brain cancer that typically has a dismal prognosis.
PharmEng's subsidiary Keata Pharma is the new owner of Pfizer's
manufacturing facility in Arnprior, Canada, which the drug giant
has been trying to pass on for over a year.
France-based Flamel Technologies and Merck Serono have shook hands
on a new €2m ($2.9m) deal which would see Flamel's Medusa
technology used to develop an extended-release profile of an
undisclosed therapeutic protein.
UK-based William Ransom & Son has a shaky future ahead
following a disappointing and unacceptable six-month financial
report, compounded by a suspension of the companys manufacturing
license.
Siegfried has signed a $27.7m contract with Arena Pharmaceuticals
to manufacture Arena's Phase III oral obesity drug candidate
lorcaserin hydrochloride.
Merck has been hit with a contamination threat prompting the recall
of a million of its childhood Hib vaccines across the US, right
alongside the Canadian suspension of its MMR vaccine.
GE Healthcare and Novavax have a vision - a state-of-the-art
pandemic influenza vaccine manufacturing facility solution with the
ability to produce vaccines quickly, which can be marketed as a
product to international countries.
UK-based William Ransom & Son has been advised to voluntarily
recall certain products following a false contamination scare at
its Witham, Essex, facility.
Bristol-Myers Squibb (BMS) has finally detailed its plans to trim
the fat and save cash, months after first revealing that big
changes would be on the cards.
Pharmaceutical Profiles, H.D. Smith, Consort Medical, Questcor
Pharmaceuticals, and Sunesis Pharmaceuticals have all had people on
the move in the world of pharmaceutical manufacturing.
